Location of Focal Vasospasm Provoked by Ergonovine maleate (cas 129-51-1) Within Coronary Arteries in Patients With Vasospastic Angina Pectoris
-
Add time:09/25/2019 Source:infona.pl
This study examined whether coronary focal vasospasm occurs in a nonuniform distribution within the coronary tree and whether a longitudinal plaque distribution pattern is present in patients with vasospastic angina using 3-dimensional intravascular ultrasound analysis. Of 121 patients with clinically suspected angina without fixed stenosis in the coronary arteries, vasospasm was provoked in 82 patients with 92 lesions (42 focal, 50 diffuse) by intravenous Ergonovine maleate (cas 129-51-1) injection. Most focal vasospasms occurred in the proximal third of the coronary arteries (proximal 28, mid 8, distal 6, p <0.01), corresponding to the historical high-risk zones for acute coronary occlusion. More plaque burden also existed in the proximal third of the coronary arteries in patients with focal vasospasm.
We also recommend Trading Suppliers and Manufacturers of Ergonovine maleate (cas 129-51-1). Pls Click Website Link as below: cas 129-51-1 suppliers
Prev:Suramin-induced neuropathy in an animal model
Next:ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or Ergonovine maleate (cas 129-51-1) in patients with Brugada syndrome) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography09/29/2019
- Refractory ergonovine-induced coronary vasospasm: Importance of intracoronary nitroglycerin09/28/2019
- Different Contractile Effects of Ergonovine and Methylergonovine in Isolated Human Coronary Arteries10/01/2019
- Coronary hemodynamic effects of Ergonovine maleate (cas 129-51-1) in human subjects09/27/2019
- ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or Ergonovine maleate (cas 129-51-1) in patients with Brugada syndrome09/26/2019


